| Nonnative Protein Polymers: Structure, Morphology, and Relation to Nucleation and Growth Biophysical Journal, Volume 93, Issue 12, 15 December 2007, Pages 4392-4403 William F. Weiss, Travis K. Hodgdon, Eric W. Kaler, Abraham M. Lenhoff and Christopher J. Roberts Abstract Thermally induced aggregates of -chymotrypsinogen A and bovine granulocyte-colony stimulating factor in acidic solutions were characterized by a combination of static and dynamic light scattering, spectroscopy, transmission electron microscopy, and monomer loss kinetics. The resulting soluble, high-molecular weight aggregates (∼10–10kDa) are linear, semiflexible polymer chains that do not appreciably associate with one another under the conditions at which they were formed, with classic power-law scaling of the radius of gyration and hydrodynamic radius with weight-average molecular weight (). Aggregates in both systems are composed of nonnative monomers with elevated levels of -sheet secondary structure, and bind thioflavine T. In general, the aggregate size distributions showed low polydispersity by light scattering. Together with the inverse scaling of with protein concentration, the results clearly indicate that aggregation proceeds via nucleated (chain) polymerization. For -chymotrypsinogen A, the scaling behavior is combined with the kinetics of aggregation to deduce separate values for the characteristic timescales for nucleation () and growth (), as well as the stoichiometry of the nucleus (). The analysis illustrates a general procedure to noninvasively and quantitatively determine , , and for soluble (chain polymer) aggregates, as well as the relationship between / and aggregate . Abstract | Full Text | PDF (880 kb) |
| Insertion of Telomere Repeat Sequence Decreases Plasmid DNA Condensation by Cobalt (III) Hexaammine Biophysical Journal, Volume 74, Issue 3, 1 March 1998, Pages 1484-1491 Jason R. Schnell, Judith Berman and Victor A. Bloomfield Abstract Telomere repeat sequence (TRS) DNA is found at the termini of most eukaryotic chromosomes. The sequences are highly repetitive and G-rich (e.g., [CA/TG] for the yeast ) and are packaged into nonnucleosomal protein-DNA structures in vivo. We have used total intensity light scattering and electron microscopy to monitor the effects of yeast TRS inserts on in vitro DNA condensation by cobalt (III) hexaammine. Insertion of 72 bp of TRS into a 3.3-kb plasmid depresses condensation as seen by light scattering and results in a 22% decrease in condensate thickness as measured by electron microscopy. Analysis of toroidal condensate dimensions suggests that the growth stages of condensation are inhibited by the presence of a TRS insert. The depression in total light scattering intensity is greater when the plasmid is linearized with the TRS at an end (39–49%) than when linearized with the TRS in the interior (18–22%). Circular dichroism of a 95-bp fragment containing the TRS insert gives a spectrum that is intermediate between the A-form and B-form, and the anomalous condensation behavior of the TRS suggests a noncanonical DNA structure. We speculate that under conditions in which the plasmid DNA condenses, the telomeric insert assumes a helical geometry that is similar to the A-form and is incompatible with packing into the otherwise B-form lattice of the condensate interior. Abstract | Full Text | PDF (288 kb) |
| Structural Effects of Cobalt-Amine Compounds on DNA Condensation Biophysical Journal, Volume 77, Issue 3, 1 September 1999, Pages 1556-1561 Hong Deng and Victor A. Bloomfield Abstract Light scattering and electron microscopy have been used to investigate the structural effects of the trivalent complexes hexaammine cobalt (III) chloride (Cohex), tris(ethylenediamine) cobalt(III) chloride (Coen), and cobalt(III) sepulchrate chloride (Cosep) on DNA condensation. These cobalt-amine compounds have similar ligand coordination geometries but differ slightly in size. Their hydrophobicity is in the order Cosep>Coen>Cohex, according to the numbers of methylene groups in these ligands. All of these compounds effectively precipitate DNA at high concentrations; but despite a lower surface charge density, Cosep condenses DNA twice as effectively as Coen or Cohex. UV and CD measurements of the supernatants of cobalt-amine/DNA solutions reveal a preferential binding of Δ-Coen over Λ-Coen to the precipitated DNA, but there is no chiral selectivity for Cosep. Competition experiments show that the binding strengths of these three cobalt-amine compounds to aggregated DNA are comparable. A charge neutralization of 88–90% is required for DNA condensation. Our data indicate that 1) electrostatic interaction is the main driving force for binding of multivalent cations to DNA; 2) DNA condensation is dependent on the structure of the condensing agent; and 3) the hydration pattern or polarization of water molecules on the surface of condensing agents plays an important role in DNA condensation and chiral recognition. Abstract | Full Text | PDF (476 kb) |
Copyright © 2007 The Biophysical Society. All rights reserved.
Biophysical Journal, Volume 92, Issue 1, 185-191, 1 January 2007
doi:10.1529/biophysj.106.093559
Nucleic Acids
Haijia Yu, Jinsong Ren and Xiaogang Qu
, 
Address reprint requests to Xiaogang Qu, Division of Biological Inorganic Chemistry, Key Laboratory of Rare Earth Chemistry and Physics, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin 130022, China. Tel.: 86-431-526-2656; Fax: 86-431-5262656.Amyloid β (Aβ) is a 39–43 amino acid polypeptide that is proteolytically derived from the transmembrane amyloid precursor protein 1,2,3. Aβ is the main component of neuritic plaques in the brains of Alzheimer’s disease (AD) patients 4. Aβ40 is the predominant peptide species at the heterogeneous carboxyl terminus 5,6.
AD is a neurodegenerative disorder of complex origin. The mechanism of Aβ neurotoxicity is controversial. Previous studies found that intracellular aggregates of Aβ were toxic and that neurotoxicity was related to the degree of Aβ aggregation 7,8,9. Furthermore, it was recently reported that soluble oligomeric species of Aβ were more toxic than nonsoluble species 10,11.
Aβ aggregate formation is influenced by various experimental conditions 12,13,14, including pH, ionic strength, metal ions, membrane-like surface, incubation time, temperature, and hydration forces. In vitro studies 15,16,17 have demonstrated that low concentrations of Aβ induce neuronal apoptosis with DNA condensation, and using fluorescence microscopy, DNA condensation was observed in cells treated with Aβ15,17. Furthermore, studies of DNA conformation in the hippocampus of AD brains 18 showed Z-DNA conformation, and supercoiled DNA treated with Aβ was more compact and condensed than nontreated DNA 19. However, the mechanism of condensation is obscure. DNA condensation is important in the cell cycle. It is involved in many biological processes, including gene expression 20 and chromosomal changes 21, and it is crucial for successful gene therapy. Thus, examining interactions of Aβ and DNA will be helpful for understanding Aβ neurotoxicity.
Aβ undergoes a time-dependent structural transition 13,22 from random coil to β-sheet in aqueous solutions, and this transition is thought to be related to its neurotoxicity. In this study, we studied the interactions between Aβ and DNA using circular dichroism, fluorescence spectroscopy, a replacement binding assay, electrophoresis, atomic force microscopy (AFM), and metal ion inhibition. We found that low concentrations of Aβ induced DNA condensation in a time-dependent manner. Additionally, Aβ-sheets, serving as condensation nuclei, were crucial for DNA condensation, and both Cu2+ and Zn2+ ions inhibited Aβ sheet-induced DNA condensation.
Aβ40 (lot No. 091K49551) and Aβ1–12 (lot No. 122K1377) were purchased from Sigma (St. Louis, MO). The peptide was first dissolved in 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) at the concentration of 1mg/ml. The solution was shaking at 4°C for 2h in a sealed vial for further dissolution and was then stored at −20°C as a stock solution 22. Before use, the solvent HFIP was removed by evaporation under a gentle stream of nitrogen and peptide was dissolved in 20mM Tris buffer, pH 7.4.
PolydGdC:polydGdC was a product of Pharmacia (Uppsala, Sweden, lot No. 2087910021) and calf thymus DNA was purchased from Sigma and purified as described earlier 23. HFIP was obtained from Acros Organics (Geel, Belgium). Ethidium bromide (EB) was purchased from USB (Cleveland, OH). (3-Aminopropyl) triethoxysilane (APTES) was purchased from Aldrich (St. Louis, MO). Solutions were all prepared in ultrapure water purified through a Milli-Q system (Millipore, Billerica, MA).
Circular dichroism (CD) spectra of polydGdC:polydGdC with Aβ40 at different incubation time were measured from 200nm to 380nm on a JASCO (Tokyo, Japan) J-810 spectropolarimeter with a computer-controlled water bath 24,25. The optical chamber of CD spectrometer was deoxygenated with dry purified nitrogen (99.99%) for 45min before use and kept the nitrogen atmosphere during experiments. Three scans were accumulated and automatically averaged.
We used EB as a fluorescent probe to characterize DNA condensation because EB would be excluded out of their DNA binding sites when DNA condensed and its fluorescence would become comparable to that of free EB molecules 23. Fluorescence measurements were carried out on a JASCO FP-6500 spectrofluorometer at 20°C 25. Fluorescence spectra were monitored at different incubation time. The EB emission signal at 585nm was translated as a relative value as (F-F0)/(Fmax-F0), where F0 and Fmax are the EB fluorescence intensity of free and bound with DNA.
The DNA condensation was monitored by light scattering on a JASCO FP-6500 spectrofluorimeter. The increasing intensity of light scattered at 90° from the incident beam was measured at 330nm along with the increased incubation time.
Absorbance measurements and melting experiments were made on a Cary 300 (Varian, Palo Alto, CA) UV/Vis spectrophotometer, equipped with a Peltier temperature control accessory 23,24. All UV/Vis spectra were measured from 190nm and 340nm in 1.0cm-path length cell.
An AFM (Nanoscope IIIa, Digital Instruments, Santa Barbara, CA) was used to image polydGdC:polydGdC in the presence or absence of Aβ peptide at different incubation time. The sample solution was deposited onto a piece of freshly cleaved mica and rinsed with water and dried before measurements 23. Tapping mode was used to acquire the images under ambient condition.
DNA and DNA/Aβ40 samples were prepared at room temperature with different incubation time. The samples were then loaded on 0.8% agarose electrophoresis (with TAE buffer) at 8V/cm during the room temperature for 30min. After EB stained DNA was visualized and photographed 25.
To determine whether Aβ influences DNA conformation, we measured CD spectra of polydGdC:polydGdC in the absence and presence of Aβ. Figure 1A showed B-form DNA with two typical bands at 250nm and 272nm in the absence of Aβ. In accordance with previous results 26 there was no immediate change in CD intensity when Aβ was added. However, the 250nm and 272nm bands diminished with longer incubation time at room temperature. During the initial 1–2 day incubation, the CD intensity decreased slowly and then more rapidly as incubation continued (Figure 1B). Ultimately, the bands nearly disappeared, and a 230nm negative CD band appeared. A 205-nm band, which is indicative of DNA structure, changed from negative to positive. Together, the changes indicate that there was a DNA conformational transition during incubation with Aβ and that the secondary structure of DNA was disturbed.
Gel retardation has been widely used to monitor DNA structural change 27, and we used gel electrophoresis to examine conformational changes in DNA during incubation with Aβ. The electrophoresis image (Fig. 2) and CD spectral analysis show that DNA underwent condensation. Initially, DNA was more compact, which may indicate a first-step condensate with a faster mobility than that of the 100 bp marker DNA, as previously reported 27. However, the quantum of that DNA form decreased over time (Fig. 2, lanes 3 and 4). Furthermore, DNA was present in the wells of the gel, which might represent complete condensation of DNA. There were no conformational changes in DNA that was incubated without Aβ (Fig. 2, lanes 5–8).
Compact DNA is resistant to intercalating dyes 28,29,30,31, and several DNA intercalators such as ToTo 28, YoYo 29, ethidium bromide (EB) 30, and syber Gold 31, have been used as fluorescent probes for DNA condensation. Here, we used an EB fluorescence quenching assay to examine DNA condensation. Figure 3A shows EB fluorescence measured at different incubation times. In DNA samples that were incubated with Aβ, EB intensity decreased, indicating that EB was excluded from binding sites. After 1 week, EB intensity was comparable to that of free equimolar EB. In contrast, there was very little change in EB intensity in DNA samples that were incubated without Aβ, even after 10 days. This observation indicates that Aβ induced DNA condensation, and it is consistent with the CD and gel electrophoresis results. In addition to polydGdC:polydGdC, we examined calf thymus DNA, which is a natural double-stranded DNA. We found that Aβ also induced calf thymus DNA condensation in a time-dependent manner (data not shown). These results indicate that Aβ can cause not only specific polydGdC:polydGdC DNA condensed but also natural DNA showing these phenomena more general. Further studies using different types of DNA are undergoing in our laboratory.
Aβ-induced DNA condensation was further demonstrated by light scattering 32. Figure 3C shows that DNA and Aβ formed aggregates in solution that scattered light. Monitoring the 90° light scattering intensity as a function of incubation time showed that the formation of DNA/Aβ aggregates was slow, as suggested by the EB replacement data.
Fig. 4 shows changes in DNA absorption at 260nm. After incubation with Aβ, absorption decreased, and the band had a red shift from 260nm to 270nm. The decrease in absorption at 260nm and the corresponding increase in scattering at 320nm imply the formation of condensates 33. DNA UV spectral changes also suggest that DNA was condensed in the presence of Aβ.
AFM was used to characterize DNA condensation and structure. After 5-day incubation, DNA/Aβ condensates were formed (Fig. 5). A large number of DNA molecules were tangled together to form condensates 23. The condensates were primarily in the form of toroidals or globules, and the particle diameter ranged from 50–200nm. This result is consistent with the electrophoresis and light scattering results.
DNA condensation was induced by the slow conformational transition of Aβ in solution. After Aβ was dissolved in buffer, it was in a random coil and did not immediately change to a β-sheet conformation. Instead, the transition to β-sheet occurred after several days of incubation at room temperature (Fig. 6), in agreement with previous reports 13,22. We assume that the β-sheet served as condensation nuclei to induce DNA condensation. For comparison, we incubated polydGdC:polydGdC with Aβ at 2°C, and did not observe any changes to DNA secondary structure (Fig. 7). This indicates that formation of β-sheets is important for DNA condensation, since low temperatures can destabilize hydrophobic interactions and inhibit the transition of Aβ to β-sheets 34. Another evidence to support β-sheet inducing DNA condensation was that Aβ1–12 could not make DNA condensation under the same conditions used for Aβ1–40. Gel electrophoresis showed that DNA was not condensed with incubation of Aβ1–12 (Fig. 8), and CD spectra (Fig. 9) indicated that Aβ1–12 did not change to a β-sheet conformation, in accordance with previous studies on Aβ1–13 35, demonstrating that β-sheet conformation is crucial for inducing DNA condensation.
Aβ is a metalloprotein. Both Cu2+ and Zn2+ bind to Aβ and can prevent or delay the formation of fibrils with β-sheet conformation 22,36. We studied the effects of Cu2+ and Zn2+ on DNA/Aβ interactions. As shown in Fig. 10, both ions delayed Aβ-induced DNA condensation. The results provide indirect evidence that β-sheets are an active inducer of DNA condensation.
Prion protein is an amyloid-forming protein, and like AD, prion disease results from protein misfolding with a conformational transition from α-helix to β-sheet. Regarding the interaction of prion protein (or its fragment PrP106–126) and DNA, previous studies have shown that DNA promotes prion protein polymerization and induces time-dependent DNA condensation 37,38. This is in keeping with our conclusion that β-sheets induce time-dependent DNA condensation. It is known that α-helix and β-sheet structures of proteins interact with DNA. The β-sheet structure interacts favorably with DNA, and H-bonds may form between peptide NH groups and deoxyribose O-3′ atoms 39. According to this assumption, Aβ may be folded in a predominantly β-sheet secondary structure, which is promoted by the presence of DNA, and serve as a condensation nuclei, which increases its propensity to aggregate with DNA during incubation.
Aβ is the major constituent of senile plaques, and although the mechanisms that lead to Aβ accumulation are not clear, Aβ is involved in AD pathogenesis, and may be the predominant causative factor of AD 2. A link has been made between AD and nucleic acid through the identification of mRNA in senile plaques. As shown by acridine orange histochemistry, RNA is one of the nonproteinaceous components of neurofibrillary tangles and senile plaques 40,41. High affinity RNA aptamers against Aβ were isolated, and β-sheet conformation was thought to be the RNA binding form 42. Previous results indicate that intracellular accumulation of Aβ rather than extracellular deposition of Aβ induce apoptosis 43,44. Aβ localized in the nuclear region of AD cells 19 enable structural alteration of DNA.
Oxidative damage to DNA in AD brains may play a role in cell death 45. Previous studies have also shown changes in chromatin from a normal euchromatin structure to a condensed heterochromatin structure 46. Recently, rigid, non-B DNA conformations were observed in severely affected AD brains 18, and it was shown that Aβ can modulate helical properties of DNA, especially supercoiled DNA 19. Interactions among biomolecules are often modulated by their conformation. Aβ exists in several conformations 47, based on incubation time and temperature in vitro. Our results indicate that in the presence of Aβ, DNA was condensed and its structure was disturbed with increasing incubation time. DNA condensation can influence gene expression and transcription in AD cells. Previous studies 15,16,17 have shown that low concentrations of Aβ induced neuronal apoptosis with DNA condensation. Therefore, the interactions of Aβ and DNA are important and may have a role in the pathogenesis of AD 18,19,45,46, the mechanisms of which need further clarification.
In summary, our results indicate that Aβ induces double-stranded DNA condensation in vitro, and the condensation is time-dependent, as examined with circular dichroism, fluorescence spectroscopy, a replacement binding assay, electrophoresis, AFM, and metal ion inhibition. β-sheets, serving as condensation nuclei, are crucial for inducing DNA condensation.
The authors are grateful for the referees’ helpful comments on the manuscript.
This project was supported by the National Natural Science Foundation of China (20225102, 20331020, 20325101, 20473084), funds from Jilin Province and Hundred People Program from the Chinese Academy of Sciences.
1. (1985). Amyloid plaque core protein in Alzheimer’s disease and Down syndrome. Proc. Natl. Acad. Sci. USA 82, 4245–4249. CrossRef | PubMed
2. (1996). Amyloid β-protein and the genetics of Alzheimer’s disease. J. Biol. Chem. 271, 18295–18298. PubMed
3. (1996). The conformation of Alzheimer’s β peptide determines the rate of amyloid formation and its resistance to proteolysis. Biochem. J. 314, 701–707. PubMed
4. (1992). β-Amyloid precursor protein cleavage by a membrane bound protease. Proc. Natl. Acad. Sci. USA 89, 6075–6079. CrossRef | PubMed
5. (1992). Mass spectrometry of purified amyloid β protein in Alzheimer’s disease. J. Biol. Chem. 267, 17062–17086. PubMed
6. (2004). Cell biology of protein misfolding: The examples of Alzheimer’s and Parkinson’s diseases. Nat. Cell Biol. 6, 1054–1061. CrossRef | PubMed
7. (1993). Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13, , 1676-1687. PubMed
8. (1995). Structure-activity analyses of β-amyloid peptides: contributions of the β25–35 region to aggregation and neurotoxicity. J. Neurochem. 64, 253–265. PubMed
9. (1994). β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl. Acad. Sci. USA 91, 12243–12247. CrossRef | PubMed
10. (1998). Diffusible, nonfibrillar ligands derived from Abeta1–42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA 95, 6448–6453. CrossRef | PubMed
11. (2003). Selective neuronal degeneration induced by soluble oligomeric amyloid beta protein. FASEB J. 17, 118–120. PubMed
12. (1991). Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer’s disease. J. Mol. Biol. 218, 149–163. CrossRef | PubMed
13 Bush, A. I., W. H. Pettingell, G. Multhaup, M. D. Paradis, J. P. Vonsattel, J. F. Gusella, K. Beyreuther, C. L. Masters, and R. E. Tanzi. Rapid induction of Alzheimer Aβ amyloid formation by zinc. Science 265:1464–1467..
14. (1994). Manipulating the Amyloid-β aggregation pathway with chemical chaperones. J. Biol. Chem. 274, 32970–32974. CrossRef | PubMed
15. (2004). Genistein ameliorates β-amyloid peptide (25–35)-induced hippocampal neuronal apoptosis. Free Radical Bio. Med. 36, 180–188. PubMed
16. (1999). The nonfibrillar amyloid β-peptide induces apoptotic neuronal cell death: involvement of its C-terminal fusogenic domain. J. Neurochem. 73, 1626–1634. CrossRef | PubMed
17. (1997). Amyloid β-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells. J. Neurochem. 68, 1870–1881. PubMed
18. (2002). First evidence to show the topological change of DNA from B-DNA to Z-DNA conformation in the hippocampus of Alzheimer’s brain. NeuroMol. Med. 2, 289–298. PubMed
19. (2003). First evidence for helical transitions in supercoiled DNA by amyloid beta peptide(1–42) and aluminum-A new insight in understanding Alzheimer’s disease. J. Mol. Neurosci. 22, 19–31. CrossRef | PubMed
20. (2003). Polyamine-dependent gene expression. Cell. Mol. Life Sci. 60, 1394–1406. CrossRef | PubMed
21. (1993). Topography of the histone octamer surface: repeating structural motifs utilized in the docking of nucleosomal DNA. Proc. Natl. Acad. Sci. USA 90, 10489–10493. CrossRef | PubMed
22. (2001). New insights on how metals disrupt amyloid β-aggregation and their effects on amyloid-β cytotoxicity. J. Biol. Chem. 276, 32293–32299. CrossRef | PubMed
23. (2006). Carbon nanotubes selective destabilization of duplex and triplex DNA and inducing B-A transition in solution. Nucleic Acids Res. 34, 3670–3676. CrossRef | PubMed
24. (2006). PolydA and polyrA self-structured by A auropium and amino acid complex. FEBS Lett. 580, 3726–3730. CrossRef | PubMed
25. (2006). Reversible B/Z-DNA transition under the low salt condition and non-B-form PolydApolydT selectivity by a cubane-like Europium-L-aspartic acid complex. Biophys. J. 90, 3203–3207. Abstract | Full Text | PDF (214 kb) | CrossRef | PubMed
26. (2003). Challenges and excitements in understanding of abeta peptides and aluminium induce helical transitions in supercoiled DNA and POL. J. Neurochem. 87, , 93–93 (Suppl.). PubMed
27. (2005). Monomolecular DNA nanoparticles for intravenous Delivery of genes. J. Am. Chem. Soc. 127, 11436–11441. CrossRef | PubMed
28. (1998). Self- assembly of DNA–polymer complexes using template polymerization. Nucleic Acids Res. 26, 4178–4185. CrossRef | PubMed
29. (2002). Structure and dynamics of condensed DNA probed by 1,1’-(4,4,8,8-Tetramethyl-4,8-diazaundecamethylene)bis[4-[[3-methylbenz- 1,3-oxazol- 2-yl]methylidine]-1,4-dihydroquinolinium] tetraiodide fluorescence. Biochemistry 41, 15277–15287. PubMed
30. (1996). Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry 35, 5616–5623. PubMed
31. (2000). A potent new class of reductively activated peptide gene delivery agents. J. Biol. Chem. 275, 9970–9977. CrossRef | PubMed
32 Thual, C., A. A. Komar, L. Bousset, E. Fernandez-Bellot, C. Cullin, and R. Melki. Structural characterization of Saccharomyces cerevisiae prion-like protein Ure2. J. Biol. Chem. 274:13666–13614..
33. (1999). Ethanol-induced condensation of calf thymus DNA studied by laser light scattering. J. Phys. Chem. B. 103, 5117–5121. PubMed
34. (2001). Inhibition of Alzheimer’s disease b-amyloid aggregation, neurotoxicity, and in vivo deposition by nitrophenols: implications for Alzheimer’s therapy. FASEB J. 15, 1297–1299. PubMed
35. (2000). Toxicity of non-Ab component of Alzheimer’s disease amyloid, and N-terminal fragments thereof, correlates to formation of b-sheet structure and fibrils. Eur. J. Biochem. 267, 2186–2194. CrossRef | PubMed
36. (2001). Cu2+ inhibits the aggregation of amyloid β-peptide(1–42) in vitro. Angew. Chem. Int. Ed. Engl. 40, 2274–2277. CrossRef | PubMed
37. (1999). Polymerization of murine recombinant prion protein in nucleic acid solution. Arch. Virol. 144, 1751–1763. CrossRef | PubMed
38. (2001). Murine recombinant prion protein induces ordered aggregation of linear nucleic acids to condensed globular structures. Arch. Virol. 146, 327–345. CrossRef | PubMed
39. (1977). Secondary structural complementarity between DNA and proteins. Proc. Natl. Acad. Sci. USA 74, 1458–1462. CrossRef | PubMed
40. (1999). Predominance of neuronal mRNAs in individual Alzheimer’s disease senile plaques. Ann. Neurol. 45, 174–181. CrossRef | PubMed
41. (1998). RNA sequestration to pathological lesions of neurodegenerative diseases. Acta Neuropathol. (Berl.) 96, 487–494. CrossRef | PubMed
42. (2002). Selection of RNA aptamers to the Alzheimer’s disease amyloid peptide. Biochem. Biophys. Res. Commun. 290, 1583–1588. CrossRef | PubMed
43. (2002). Intracellular amyloid-β1–42, but not extracellular soluble amyloid-β peptides, induces neuronal apoptosis. J. Biol. Chem. 277, 15666–15670. CrossRef | PubMed
44. (2000). Intraneuronal Aβ42 accumulation in human brain. Am. J. Pathol. 156, 15–20. PubMed
45. (1997). An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer’s disease. J. Neurochem. 68, 2061–2069. PubMed
46. (1979). Altered chromatin conformation in Alzheimer’s disease. Brain 102, 483–495. PubMed
47. (1996). The interaction between Apolipoprotein E and Alzheimer’s amyloid β-peptide is dependent on β-peptide conformation. J. Biol. Chem. 271, 10602–10606. CrossRef | PubMed